Analysis of Factors Determining Success in FFPE Based NGS Panel Testing For Lung & Ovarian Cancer

P. Bhattacharya, P. Bishop, D. Gokhale, S. Rowlston, B. Eggington, G. J. Burghel, H. Schlecht
doi: https://doi.org/10.1101/2024.07.29.24311158

Article Information

doi 
https://doi.org/10.1101/2024.07.29.24311158
History 
  • July 29, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. P. Bhattacharya1,*,
  2. P. Bishop2,
  3. D. Gokhale1,
  4. S. Rowlston1,
  5. B. Eggington2,
  6. G. J. Burghel1,3 and
  7. H. Schlecht1
  1. 1Manchester Centre for Genomic Medicine, Manchester University Foundation Trust, Manchester, United Kingdom
  2. 2Department of Pathology, Manchester University Foundation Trust, Manchester, United Kingdom
  3. 3Division of Evolution, Infection and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
  1. ↵*Corresponding author; Email: priyanka.bhattacharya{at}mft.nhs.uk
Back to top
Posted July 29, 2024.
Download PDF
Data/Code
Email
Analysis of Factors Determining Success in FFPE Based NGS Panel Testing For Lung & Ovarian Cancer
P. Bhattacharya, P. Bishop, D. Gokhale, S. Rowlston, B. Eggington, G. J. Burghel, H. Schlecht
medRxiv 2024.07.29.24311158; doi: https://doi.org/10.1101/2024.07.29.24311158
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area